News + Insights

Now Open: SPARK NS Call for Proposals, 2027 Cohort Principal investigators with promising discoveries in autism and Parkinson's disease in the US, Canada, the UK, and Europe are encouraged to apply.
Ariella Bersan Video
Nine Principal Investigators Join the SPARK NS Program, 2026 Cohort
Multiple authors Video
SPARK NS and Haukeland Univ Hospital Begin Parkinson's Clinical Trial
Susan Thomas
Starting with the End in Mind
Opher Kornfeld, PhD
What Surprised an Academic About Drug Development
Daria Mochly-Rosen, PhD
Identifying Unmet Medical Need
Kevin Grimes, MD, MBA
When Motherhood Meets Science
Ariella Bersan

Spotlight

Miratul Muqit, MBChB, PhD: A Study In PINK

Parkinson’s researcher pursues therapies that can prevent the loss of brain cells that will slow or stop the progression of the disease.

Spotlight

Miratul Muqit, MBChB, PhD, University of Dundee & UK Dementia Research (UK DRI) Institute Parkinson’s Research Centre

Get Involved

Call for Proposals

SPARK NS is accepting applications for the SPARK NS Translational Research Program, 2027 Cohort. Principal investigators developing therapeutics for autism and Parkinson's disease in the United States, Canada, the United Kingdom, and Europe are invited to apply.

All theDetails

Explore the SPARK NS Translational Research Program

The funding and high-level of support provided by our program helps ensure that each project selected for participation meets its translational objectives and continues on the path to market.

LearnMore